iodoacetamide has been researched along with Lymphoma, T-Cell in 2 studies
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, M | 2 |
| Buckley, DJ | 2 |
| Lavoi, KP | 1 |
| Buckley, AR | 2 |
| Blake, MJ | 2 |
| Gout, PW | 1 |
2 other studies available for iodoacetamide and Lymphoma, T-Cell
| Article | Year |
|---|---|
Heat-induced proteolysis of HSF causes premature deactivation of the heat shock response in Nb2 lymphoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cycloheximide; Cysteine Proteinase Inhibitors; DNA-Binding Protein | 1998 |
Proteolysis of heat shock transcription factor is associated with apoptosis in rat Nb2 lymphoma cells.
Topics: Alkylating Agents; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents, Phytogenic; Apop | 1999 |